Geert Vanden Bossche
Chief Innovation & Scientific Officer
Geert Vanden Bossche obtained his DVM at the Veterinary Faculty of Ghent and his PhD in Virology at the University of Hohenheim, Stuttgart. Following his postdoctoral training in Virology, Immunology and Molecular Biology at the Free University of Berlin and the University of Hohenheim (Germany), where he subsequently held adjunct faculty appointments, he transitioned to the Vaccine Industry to serve various senior roles in both early and late vaccine development. He then joined the Bill & Melinda Gates Foundation in Seattle to serve as Senior Program Officer in Vaccine Discovery for Global Health. Furthermore, Geert also founded UNIVAC, coordinated the Ebola Vaccine Program on behalf of GAVI and serves as a visiting scientist at the REGA Institute, University of Leuven (Belgium). Geert is board certified in Virology and Microbiology, the author of over 30 publications, and inventor on a patent application for universal vaccines. He has presented vaccine- and adjuvant-related topics at multiple international congresses.
Vaccine adjuvants, critical assessment of novel vaccine approaches or technologies, Vaccine development, immunopathogenesis of infectious and immune-mediated, noninfectious disease.